Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 8, 2012 - Issue 1
Submit an article Journal homepage
6,098
Views
66
CrossRef citations to date
0
Altmetric
Review

Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies

David I Hong Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
,
Lora Bankova Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
,
Katherine N Cahill Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
,
Timothy Kyin Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
&
Mariana C Castells[email protected]
Pages 43-54 | Published online: 10 Jan 2014

Citations (66)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Wolf-Henning Boehncke & Nicolo Costantino Brembilla. (2018) Immunogenicity of biologic therapies: causes and consequences. Expert Review of Clinical Immunology 14:6, pages 513-523.
Read now
Allison Worth & Aziz Sheikh. (2013) Prevention of anaphylaxis in healthcare settings. Expert Review of Clinical Immunology 9:9, pages 855-869.
Read now

Articles from other publishers (64)

Madeline Robinson, Marc Geirnaert, Brady Anderson & Lundy McKibbin. (2023) Canada’s First Joint Oncology-Allergy Clinic: Successful Desensitization to Trastuzumab Following Severe Anaphylactic Reaction in Which Epinephrine Was Inappropriately Withheld. Current Oncology 30:3, pages 2862-2868.
Crossref
Iuliana Iordan, Dan-Corneliu Jinga, Claudiu Dragoş Popescu & Ana Maria Vlădăreanu. (2023) Complicaţii mediate imunologic ale anticorpilor monoclonali folosiţi în oncohematologie. Oncolog-Hematolog.ro 1:62, pages 26.
Crossref
David A. Khan, Aleena Banerji, Kimberly G. Blumenthal, Elizabeth J. Phillips, Roland Solensky, Andrew A. White, Jonathan A. Bernstein, Derek K. Chu, Anne K. Ellis, David B.K. Golden, Matthew J. Greenhawt, Caroline C. Horner, Dennis Ledford, Jay A. Lieberman, John Oppenheimer, Matthew A. Rank, Marcus S. Shaker, David R. Stukus, Dana Wallace, Julie Wang, David A. Khan, David B.K. Golden, Marcus Shaker, David R. Stukus, David A. Khan, Aleena Banerji, Kimberly G. Blumenthal, Elizabeth J. Phillips, Roland Solensky, Andrew A. White, Jonathan A. Bernstein, Derek K. Chu, Anne K. Ellis, David B.K. Golden, Matthew J. Greenhawt, Caroline C. Horner, Dennis Ledford, Jay A. Lieberman, John Oppenheimer, Matthew A. Rank, Marcus S. Shaker, David R. Stukus, Dana Wallace & Julie Wang. (2022) Drug allergy: A 2022 practice parameter update. Journal of Allergy and Clinical Immunology 150:6, pages 1333-1393.
Crossref
M Dupont, Claire Carlier, C Gower-Rousseau, P Barbier-Lider, D Botsen, M Brasseur, A Burgevin, C Chourbagi, R D’Almeida, V Hautefeuille, M Hentzien, A Lambert, M Lamuraglia, S Lavau-Denes, A Lopez, D Parent, F Slimano, M Brugel & O Bouché. (2022) Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?. BMC Cancer 22:1.
Crossref
Ricardo Madrigal-Burgaleta, Maria Antonieta Guzman-Melendez & Emilio Alvarez-Cuesta. (2022) New Technical Aspects Used in the Management of Desensitization to Antineoplastic Drugs. Current Treatment Options in Allergy 9:3, pages 204-218.
Crossref
Emilio Alvarez-Cuesta, Ricardo Madrigal-Burgaleta, Ana D. Broyles, Javier Cuesta-Herranz, Maria Antonieta Guzman-Melendez, Michelle C. Maciag, Elizabeth J. Phillips, Jason A. Trubiano, Johnson T. Wong, Ignacio Ansotegui, F. Runa Ali, Denisse Angel-Pereira, Aleena Banerji, Maria Pilar Berges-Gimeno, Lorena Bernal-Rubio, Knut Brockow, Ricardo Cardona Villa, Mariana C. Castells, Jean-Christoph Caubet, Yoon-Seok Chang, Luis Felipe Ensina, Manana Chikhladze, Anca Mirela Chiriac, Weng-Hung Chung, Motohiro Ebisawa, Bryan Fernandes, Lene Heise Garvey, Maximiliano Gomez, Javier Gomez Vera, Sandra Gonzalez Diaz, David I. Hong, Juan Carlos Ivancevich, Hye-Ryun Kang, David A. Khan, Merin Kuruvilla, Jose Ignacio Larco Sousa, Patricia Latour-Staffeld, Anne Y. Liu, Eric Macy, Hans Jorgen Malling, Jorge Maspero, Sara M. May, Cristobalina Mayorga, Miguel A. Park, Jonathan Peter, Matthieu Picard, Tito Rodriguez-Bouza, Antonino Romano, Mario Sanchez-Borges, Luciana Kase Tanno, Maria Jose Torres, Alicia Ureña-Tavera, Rocco L. Valluzzi, Gerald W. Volcheck & Masao Yamaguchi. (2022) Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement. World Allergy Organization Journal 15:6, pages 100640.
Crossref
Hatice Betul Gemici Karaaslan, Esra Karabag Yilmaz, Ruveyda Gulmez, Nur Canpolat, Ayca Kiykim & Haluk Cezmi Cokugras. (2022) Omalizumab may facilitate drug desensitization in patients failing standard protocols. Pediatric Allergy and Immunology 33:5.
Crossref
Hyun Hwa Kim, Jeongmin Seo, Yoon Hae Ahn, Hyunjee Kim, Jeong-Eun Yoon, Jang Ho Suh, Dong Yoon Kang, Suh Young Lee & Hye-Ryun Kang. (2022) Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol. Frontiers in Allergy 3.
Crossref
Sevim Bavbek, Mauro Pagani, Emilio Alvarez‐Cuesta, Mariana Castells, Adile Berna Dursun, Sahar Hamadi, Ricardo Madrigal‐Burgaleta, Soledad Sanchez‐Sanchez & Alessandra Vultaggio. (2021) Hypersensitivity reactions to biologicals: An EAACI position paper. Allergy 77:1, pages 39-54.
Crossref
H. Chabane, S. Lefevre, C. Dzviga, C. Lambert, E. Seve, L. Garnier, G. Dalampira, A. Sarrat, C. Klingebiel, J. Vitte, P. Nicaise-Roland, C. Palussière, J. Bienvenu, R. Couderc, P. Demoly & J. Just. (2021) Recommandations pour la prescription et l’interprétation des examens biologiques utilisables dans le cadre du diagnostic ou du suivi des allergies, disponibles en France. Partie 4 : allergie aux médicaments. Revue Française d'Allergologie 61:7, pages 525-540.
Crossref
Anna Sala-Cunill, Gustavo-Jorge Molina-Molina, Jenny-Tatiana Verdesoto, Moisés Labrador-Horrillo, Olga Luengo, Paula Galvan-Blasco, Mar Guilarte & Victoria Cardona. (2021) One-Dilution Rapid Desensitization Protocol to Chemotherapeutic and Biological Agents: A Five-Year Experience. The Journal of Allergy and Clinical Immunology: In Practice 9:11, pages 4045-4054.
Crossref
Lola Lessard, Céline Tard, Emmanuelle Salort-Campana, Sabrina Sacconi, Pascal Laforêt, Anthony Béhin, Guillaume Bassez, David Orlikowski, Philippe Merle, Sylvain Nollet, Laure Gallay, Frédéric Bérard & Françoise Bouhour. (2021) Réactions d’hypersensibilité immédiate à l’enzymothérapie substitutive dans la maladie de Pompe : quel bilan et comment gérer la réintroduction de l’enzymothérapie substitutive en pratique clinique ?. Les Cahiers de Myologie:23, pages 32-37.
Crossref
Ana Dioun Broyles, Aleena Banerji, Sara Barmettler, Catherine M. Biggs, Kimberly Blumenthal, Patrick J. Brennan, Rebecca G. Breslow, Knut Brockow, Kathleen M. Buchheit, Katherine N. Cahill, Josefina Cernadas, Anca Mirela Chiriac, Elena Crestani, Pascal Demoly, Pascale Dewachter, Meredith Dilley, Jocelyn R. Farmer, Dinah Foer, Ari J. Fried, Sarah L. Garon, Matthew P. Giannetti, David L. Hepner, David I. Hong, Joyce T. Hsu, Parul H. Kothari, Timothy Kyin, Timothy Lax, Min Jung Lee, Kathleen Lee-Sarwar, Anne Liu, Stephanie Logsdon, Margee Louisias, Andrew MacGinnitie, Michelle Maciag, Samantha Minnicozzi, Allison E. Norton, Iris M. Otani, Miguel Park, Sarita Patil, Elizabeth J. Phillips, Matthieu Picard, Craig D. Platt, Rima Rachid, Tito Rodriguez, Antonino Romano, Cosby A. StoneJr.Jr., Maria Jose Torres, Miriam Verdú, Alberta L. Wang, Paige Wickner, Anna R. Wolfson, Johnson T. Wong, Christina Yee, Joseph Zhou & Mariana Castells. (2020) Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. The Journal of Allergy and Clinical Immunology: In Practice 8:9, pages S16-S116.
Crossref
Furkan Ayaz, Tugba Arikoglu, Ali Demirhan & Semanur Kuyucu. (2020) A novel whole blood based method for lymphocyte transformation test in drug allergies. Journal of Immunological Methods 479, pages 112745.
Crossref
Jae-Ha Lee, Mira Moon, Young-Chan Kim, Soo Jie Chung, Jihyun Oh, Dong-Yoon Kang, Suh-Young Lee, Kyung-Hun Lee, James Yun & Hye-Ryun Kang. (2020) A One-Bag Rapid Desensitization Protocol for Paclitaxel Hypersensitivity: A Noninferior Alternative to a Multi-Bag Rapid Desensitization Protocol. The Journal of Allergy and Clinical Immunology: In Practice 8:2, pages 696-703.
Crossref
Sharanya Vemula. 2020. Handbook of Cancer Treatment-Related Symptons and Toxicities. Handbook of Cancer Treatment-Related Symptons and Toxicities 107 112 .
Mohammad Solduzian, Saeed Anvari, Hamidreza Taghvaye Masoumi, Farhad Shahi & Zahra Jahangard-Rafsanjani. (2018) Successful desensitization of a patient with cetuximab hypersensitivity: A case report. Journal of Oncology Pharmacy Practice 25:7, pages 1726-1730.
Crossref
Yewon Kang, Oh Young Kwon, Heewon Jung, Minkyoung Kang, Jin An, Ji-Hyang Lee, Ha-Kyeong Won, Woo-Jung Song, Hyouk-Soo Kwon, You Sook Cho, Hee-Bom Moon & Tae-Bum Kim. (2019) Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors. Annals of Allergy, Asthma & Immunology 123:1, pages 48-56.e1.
Crossref
Dario Didona, Roberto Maglie, Rüdiger Eming & Michael Hertl. (2019) Pemphigus: Current and Future Therapeutic Strategies. Frontiers in Immunology 10.
Crossref
Ricardo Madrigal-Burgaleta, Lorena Bernal-Rubio, Maria Pilar Berges-Gimeno, Laura Victoria Carpio-Escalona, Patricia Gehlhaar & Emilio Alvarez-Cuesta. (2019) A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents. The Journal of Allergy and Clinical Immunology: In Practice 7:2, pages 618-632.
Crossref
Eva Pérez-Rodríguez, Juan Antonio Martínez-Tadeo, Natalia Pérez-Rodríguez, Guacimara Hernández-Santana, Ariel Callero-Viera, Elena Rodríguez-Plata & José Carlos García-Robaina. (2018) Outcome of 490 Desensitizations to Chemotherapy Drugs with a Rapid One-Solution Protocol. The Journal of Allergy and Clinical Immunology: In Practice 6:5, pages 1621-1627.e6.
Crossref
Ghislaine Annie C. Isabwe, Marlene Garcia Neuer, Leticia de las Vecillas Sanchez, Donna-Marie Lynch, Kathleen Marquis & Mariana Castells. (2018) Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes. Journal of Allergy and Clinical Immunology 142:1, pages 159-170.e2.
Crossref
Tamás Fülöp, Tamás Mészáros, Gergely Kozma, János Szebeni & Mihály Józsi. (2018) Infusion Reactions Associated with the Medical Application of Monoclonal Antibodies: The Role of Complement Activation and Possibility of Inhibition by Factor H. Antibodies 7:1, pages 14.
Crossref
Anne Y. Liu. 2018. Drug Allergy Testing. Drug Allergy Testing 211 221 .
E.W. Evans & S. Casinghino. 2018. Comprehensive Toxicology. Comprehensive Toxicology 306 321 .
Uni Wong & Raymond K. Cross. 2018. Treatment of Inflammatory Bowel Disease with Biologics. Treatment of Inflammatory Bowel Disease with Biologics 231 260 .
Alvise Berti, Ulrich Specks, Karina A. Keogh & Divi Cornec. (2017) Current and Future Treatment Options for Eosinophilic Granulomatosis With Polyangiitis. Current Treatment Options in Rheumatology 3:4, pages 193-206.
Crossref
Huifeng Yun, Fenglong Xie, Randall N. Beyl, Lang Chen, James D. Lewis, Kenneth G. Saag & Jeffrey R. Curtis. (2017) Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis. Arthritis Care & Research 69:10, pages 1526-1534.
Crossref
Sara K. Witting Christensen, Inge Kortekaas Krohn, Jani Thuraiaiyah, Tina Skjold, Johannes Martin Schmid & Hans Jürgen H. Hoffmann. (2017) Increasing time interval and decreasing allergen dose interval improves ex vivo desensitization of human blood basophils . Cytometry Part B: Clinical Cytometry 92:5, pages 340-347.
Crossref
E. Jensen-Jarolim, H. J. Bax, R. Bianchini, M. Capron, C. Corrigan, M. Castells, D. Dombrowicz, T. R. Daniels-Wells, J. Fazekas, E. Fiebiger, S. Gatault, H. J. Gould, J. Janda, D. H. Josephs, P. Karagiannis, F. Levi-Schaffer, A. Meshcheryakova, D. Mechtcheriakova, Y. Mekori, F. Mungenast, E. A. Nigro, M. L. Penichet, F. Redegeld, L. Saul, J. Singer, J. F. Spicer, A. G. Siccardi, E. Spillner, M. C. Turner, E. Untersmayr, L. Vangelista & S. N. Karagiannis. (2017) AllergoOncology - the impact of allergy in oncology: EAACI position paper. Allergy 72:6, pages 866-887.
Crossref
Eva Pérez-Rodríguez, Miguel Ángel Hernández-Pérez & Juan Antonio Martínez-Tadeo. (2017) Successful desensitization to natalizumab using a 1-solution protocol. Annals of Allergy, Asthma & Immunology 118:1, pages 113-114.
Crossref
Nicholas G. Kounis, Ioanna Koniari & George Hahalis. (2016) Cardio-oncology, Immuno-oncology, Onco-cardiology and Onco-immunology. International Journal of Cardiology 223, pages 254-257.
Crossref
Craig D. Platt, Loren D'Angelo, Ellis J. Neufeld & Ana Dioun Broyles. (2016) Skin testing, graded challenge, and desensitization to von Willebrand factor (VWF) products in type III von Willebrand disease (VWD). The Journal of Allergy and Clinical Immunology: In Practice 4:5, pages 1006-1008.
Crossref
Paige G. Wickner & David Hong. (2016) Immediate Drug Hypersensitivity. Current Allergy and Asthma Reports 16:7.
Crossref
V. Leroy, E. Lazaro, A.‐S. Darrigade, A. Taïeb, B. Milpied & J. Seneschal. (2016) Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction. British Journal of Dermatology 174:6, pages 1417-1418.
Crossref
C. Boin, S. Lambert, P. Thomann, O. Aujoulat & P. Kieffer. (2016) Maladie de Castleman : désensibilisation rapide après une réaction d’hypersensibilité au rituximab. La Revue de Médecine Interne 37:6, pages 433-436.
Crossref
. 2016. Textbook of Allergy for the Clinician. Textbook of Allergy for the Clinician 352 363 .
Marie Fizesan, Christopher Boin, Olivier Aujoulat, Georges Newinger, Dana Ghergus, Hervé Watier, Hélène Lustig & Mario Ojeda-Uribe. (2015) Successful rapid desensitization to the antibody–drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma. Journal of Oncology Pharmacy Practice 22:1, pages 188-192.
Crossref
Sevim Bavbek, Reşat Kendirlinan, Pamir Çerçi, Seda Altıner, Şadan Soyyiğit, Zeynep Çelebi Sözener, Ömür Aydın & Reyhan Gümüşburun. (2016) Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics. International Archives of Allergy and Immunology 171:3-4, pages 227-233.
Crossref
J Szebeni, S Fishbane, M Hedenus, S Howaldt, F Locatelli, S Patni, D Rampton, G Weiss & J Folkersen. (2015) Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. British Journal of Pharmacology 172:21, pages 5025-5036.
Crossref
Patrícia Amorós-Reboredo, Jaime Sánchez-López, Carla Bastida-Fernández, Fernando do Pazo-Oubiña, Núria Borràs-Maixenchs, Eva Giné, Antonio Valero & Natàlia Creus-Baró. (2015) Desensitization to rituximab in a multidisciplinary setting. International Journal of Clinical Pharmacy 37:5, pages 744-748.
Crossref
Lisa M. Wheatley, Marshall Plaut, Julie M. Schwaninger, Aleena Banerji, Mariana Castells, Fred D. Finkelman, Gerald J. Gleich, Emma Guttman-Yassky, Simon A.K. Mallal, Dean J. Naisbitt, David A. Ostrov, Elizabeth J. Phillips, Werner J. Pichler, Thomas A.E. Platts-Mills, Jean-Claude Roujeau, Lawrence B. Schwartz & Lauren A. Trepanier. (2015) Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. Journal of Allergy and Clinical Immunology 136:2, pages 262-271.e2.
Crossref
Mariana C. Castells. (2015) Anaphylaxis to Chemotherapy and Monoclonal Antibodies. Immunology and Allergy Clinics of North America 35:2, pages 335-348.
Crossref
J. Waton, C. Poreaux & A. Barbaud. (2015) Accoutumance aux chimiothérapies et aux biothérapies. Revue Française d'Allergologie 55:2, pages 75-77.
Crossref
Kelli W. Williams & Hemant P. Sharma. (2015) Anaphylaxis and Urticaria. Immunology and Allergy Clinics of North America 35:1, pages 199-219.
Crossref
Pinar Ataca, Erden Atilla, Resat Kendir, Sevim Bavbek & Muhit Ozcan. (2015) Successful Desensitization of a Patient with Rituximab Hypersensitivity. Case Reports in Immunology 2015, pages 1-4.
Crossref
Denis Jullien, Jörg C. Prinz & Frank O. Nestle. (2015) Immunogenicity of Biotherapy Used in Psoriasis: The Science Behind the Scenes. Journal of Investigative Dermatology 135:1, pages 31-38.
Crossref
Ellen W. Evans. (2013) Regulatory Forum Commentary*. Toxicologic Pathology 42:7, pages 1053-1057.
Crossref
Onur Boyman, Denis Comte & François Spertini. (2014) Adverse reactions to biologic agents and their medical management. Nature Reviews Rheumatology 10:10, pages 612-627.
Crossref
Brian A. Baldo & Mauro Pagani. (2014) Adverse Events to Nontargeted and Targeted Chemotherapeutic Agents. Immunology and Allergy Clinics of North America 34:3, pages 565-596.
Crossref
Amy E. O'Connell, Joyce P. Lee, Christina Yee, Jennifer Kesselheim & Anahita Dioun. (2014) Successful Desensitization to Brentuximab Vedotin After Anaphylaxis. Clinical Lymphoma Myeloma and Leukemia 14:2, pages e73-e75.
Crossref
Veronica Mezzano, Pedro Giavina-Bianchi, Matthieu Picard, Joana Caiado & Mariana Castells. (2013) Drug Desensitization in the Management of Hypersensitivity Reactions to Monoclonal Antibodies and Chemotherapy. BioDrugs 28:2, pages 133-144.
Crossref
Ingrid Bandeira Moss, Monique Bandeira Moss, Debora Silva dos Reis & Reno Martins Coelho. (2014) Immediate infusional reactions to intravenous immunobiological agents for the treatment of autoimmune diseases: experience of 2126 procedures in a non-oncologic infusion centre. Revista Brasileira de Reumatologia (English Edition) 54:2, pages 102-109.
Crossref
Ingrid Bandeira Moss, Monique Bandeira Moss, Debora Silva dos Reis & Reno Martins Coelho. (2014) Reações infusionais imediatas a agentes imunobiológicos endovenosos no tratamento de doenças autoimunes: experiência de 2.126 procedimentos em um centro de infusão não oncológico. Revista Brasileira de Reumatologia 54:2, pages 102-109.
Crossref
Laura AM Ferrari, Giuseppe Fanetti, Fabio G Rossi, Maria C BrambillaBarbara ReRoberto Buzzoni. (2018) Are Antineoplastic Drug Acute Hypersensitive Reactions a Submerged or an Emergent Problem? Experience of the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori. Tumori Journal 100:1, pages 9-14.
Crossref
David I. Hong & Anahita F. Dioun. (2014) Indications, Protocols, and Outcomes of Drug Desensitizations for Chemotherapy and Monoclonal Antibodies in Adults and Children. The Journal of Allergy and Clinical Immunology: In Practice 2:1, pages 13-19.
Crossref
Gülfem E. Çelik, Werner J. Pichler & N. Franklin AdkinsonJr.Jr.. 2014. Middleton's Allergy. Middleton's Allergy 1274 1295 .
Giuseppe TridenteGiuseppe Tridente. 2014. Adverse Events with Biomedicines. Adverse Events with Biomedicines 593 623 .
Denisa E. Ferastraoaru, Maura N. Dickler, Sima Patel, Erica A. Fischer, Melissa P. Pulitzer, Patricia L. Myskowski & Elina Jerschow. (2013) Nonimmediate Hypersensitivity Reaction After Trastuzumab Infusion: A Suspected Drug-Virus Interaction. Journal of Clinical Oncology 31:24, pages e407-e409.
Crossref
Metin Aydogan, Nail Yologlu, Gulcin Gacar, Zeynep Seda Uyan, Isil Eser & Erdal Karaoz. (2013) Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome: Increase in number of Treg cells after desensitization. Journal of Allergy and Clinical Immunology 132:2, pages 478-480.
Crossref
François Aubin, Franck Carbonnel & Daniel Wendling. (2013) The complexity of adverse side-effects to biological agents. Journal of Crohn's and Colitis 7:4, pages 257-262.
Crossref
A. Barbaud. (2013) Hypersensibilité aux biothérapies. Revue Française d'Allergologie 53:3, pages 174-178.
Crossref
ID O’Neill & C Scully. (2012) Biologics in oral medicine: oral Crohn’s disease and orofacial granulomatosis. Oral Diseases 18:7, pages 633-638.
Crossref
ID O’Neill & C Scully. (2012) Biologics in oral medicine: principles of use and practical considerations. Oral Diseases 18:6, pages 525-536.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.